OFFICE OF FISCAL ANALYSIS
Legislative Office Building, Room 5200
Hartford, CT 06106 (860) 240-0200
http://www.cga.ct.gov/ofa
April 10, 2024
ADDENDUM
To Fiscal Note on
sSB-8, File No. 309
AN ACT CONCERNING DRUG AFFORDABILITY.
Primary Analyst: ES 4/10/24
Contributing Analyst(s):
The fiscal note on the underlying bill did not include the fiscal impact
to the Department of Social Services (DSS) related to the Canadian
prescription drug importation program.
Section 2 may result in a savings to DSS associated with the Canadian
prescription drug importation program. The bill requires the program
to provide prescription drugs for Medicaid and HUSKY B that have the
highest potential for cost savings. To the extent this is achieved, and
such drugs are utilized in place of more costly drugs after accounting
for rebates, DSS would experience a corresponding savings. The extent
of any savings to Medicaid and HUSKY B cannot be determined at this
time.
If implemented, DSS would incur administrative costs of at least
$150,000 annually associated with pharmacy consultant staff.
Additional staff and/or contract support may be required depending on
the scope of the program.